# Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms

> **NCT06731946** · — · ACTIVE_NOT_RECRUITING · sponsor: **Yibin Fang** · enrollment: 150 (estimated)

## Conditions studied

- Intracranial Arterial Aneurysm

## Interventions

- **DEVICE:** Flow diverting

## Key facts

- **NCT ID:** NCT06731946
- **Lead sponsor:** Yibin Fang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-29
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731946, "Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06731946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*